Laurina (Desogestrel, Ethinylestradiol)

Desogestrel, the active ingredient in Laurina, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age.

GNH USA supplies Laurina as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Laurina, a combined oral contraceptive, is used to prevent pregnancy by inhibiting ovulation.

- Prevention of pregnancy: provides reliable contraceptive protection for women of childbearing potential. - Management of dysmenorrhea: reduces menstrual pain and improves cycle regularity. - Treatment of moderate acne: helps control hormonal acne by decreasing androgenic activity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: swelling or discomfort in the breasts. - Headache: occasional tension‑type headaches. - Spotting: irregular light bleeding between periods. - Weight gain: modest increase in body weight. - Mood changes: fluctuations in emotional state.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins or lungs. - Arterial thrombosis: clot formation in arteries leading to stroke or heart attack. - Severe hypertension: sudden, high blood pressure. - Hepatic adenoma: benign liver tumor. - Gallbladder disease: inflammation or stones. - Anaphylaxis: life‑threatening allergic reaction.

Before starting Laurina, consider the following safety points. - Contraindication: known or suspected pregnancy. - Contraindication: history of thromboembolic disorders. - Caution: smokers over 35 years of age. - Monitor: blood pressure should be checked regularly. - Avoid: concomitant use with enzyme‑inducing anticonvulsants. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Laurina may interact with other medicines; review the following.

Major Interactions (Avoid): - Potent enzyme inducers (e.g., rifampicin, carbamazepine): may markedly reduce contraceptive efficacy. - Hormone replacement therapy: combined use can increase risk of thromboembolic events.

Moderate Interactions (Monitor Closely): - Antifungals such as ketoconazole: may increase plasma levels of ethinylestradiol. - Certain antibiotics (e.g., tetracycline): may slightly lower contraceptive effectiveness. - St. John’s wort: herbal supplement that can reduce hormone levels and efficacy.